MonumenTAL-1

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Arms / Cohorts

Experimental Part 3, Cohort A:Talquetamab (No Prior T Cell Redirection Therapies)

Accepting patients

Experimental Part 3, Cohort B:Talquetamab (Prior T Cell Redirection Therapies)

Accepting patients

Experimental Part 3, Cohort C:Talquetamab Bi-Weekly

Accepting patients

Experimental Part 3, Cohort D:Talquetamab

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.